Burkhard Blank's most recent trade in Mannkind Corp was a trade of 16,151 Common Stock, $0.01 Par Value done at an average price of $4.8 . Disclosure was reported to the exchange on May 24, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mannkind Corp | Burkhard Blank | EVP Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.78 per share. | 24 May 2024 | 16,151 | 351,754 (0%) | 0% | 4.8 | 77,202 | Common Stock, $0.01 Par Value |
Mannkind Corp | Burkhard Blank | EVP Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 158,000 | 158,000 | - | - | Performance Restricted Stock Unit | |
Mannkind Corp | Burkhard Blank | EVP Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 129,000 | 496,905 (0%) | 0% | 0 | Common Stock, $.01 Par Value | |
Mannkind Corp | Blank Burkhard | EVP Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 3.27 per share. | 31 Dec 2023 | 152,905 | 367,905 (0%) | 0% | 3.3 | 499,999 | Common Stock, $0.01 Par Value |
Mannkind Corp | Blank Burkhard | EVP Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 3.09 per share. | 31 Dec 2023 | 5,000 | 215,000 (0%) | 0% | 3.1 | 15,450 | Common Stock, $0.01 Par Value |
Mannkind Corp | Burkhard Blank | EVP Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 210,000 | 210,000 | - | 0 | Restricted Stock Unit | |
Acorda Therapeutics Inc | Burkhard Blank | CMO and Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 11,125 | 18,527 (0%) | 0% | 0 | Common Stock | |
Acorda Therapeutics Inc | Burkhard Blank | CMO and Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2020 | 3,015 | 44,410 (0%) | 0% | 0 | Common Stock |